Deficiency of NR2C2 accelerates senescence of testicular Leydig cells and infertility in male mice
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2025.112284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Dalian Gong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Research Center of the Basic Discipline for Cell Signaling, College of Biology, Hunan University, Changsha 410082, China. Hauptthemen laut MEDLINE: Leydig Cells, Cellular Senescence, Infertility, Male. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Hunan Provincial Natural Science Foundation.
Abstract (Originalsprache)
The Leydig cell is one of the components that make up the testicular microenvironment, playing a crucial role in male reproductive function by secreting androgens and cytokines. The present study found that knocking down NR2C2, a member of the 2C group of the nuclear receptor family, can lead to senescent phenotype in mouse primary Leydig cells, with increased cell apoptosis and DNA damage, enhanced SA-β-Gal activity, and decreased glutathione levels. The fertility of Nr2c2 heterozygous knockout mice (Nr2c2+/-) is impaired. The testosterone levels of Nr2c2+/- mice at 12 months of age were lower than those of wild-type littermates of the same age, accompanied by increased expression of P21 protein in testicular tissue. Mechanistically, NR2C2 promotes transcription of target genes such as Akt2 and Qsox2 by binding to DR elements on their promoters. In addition, NR2C2 participates in regulating alternative splicing of target mRNAs (Rnf111, Cdkn2c, Igf1r and Fnip2) at the post transcriptional level by interacting with hnRNPH1 or other splicing factors. Our study for the first time reveals that NR2C2 is a core regulatory factor in resisting aging in testicular Leydig cells. It provides a novel potential target for male infertility and reproductive aging-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Research Center of the Basic Discipline for Cell Signaling, College of Biology, Hunan University, Changsha 410082, China.
- Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha 410007, China.
- Cancer Research Institute, Xiangya School of Basic Medicine Sciences, Central South University, Changsha 410078, China.
- Hunan Provincial Key Laboratory of Regional Hereditary Birth Defects Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha 410007, China. Electronic a…
- Hunan Research Center of the Basic Discipline for Cell Signaling, College of Biology, Hunan University, Changsha 410082, China. Electronic address: sw_ld@hnu.edu.cn.
Förderung
- National Key Research and Development Program of China
- Hunan Provincial Natural Science Foundation
Zitieren
APA
Gong, D., Liu, Z., Kang, R., Liu, X., Min, Z., Xin, H., Liu, Y., Chen, Y., Liu, M., Liang, Y., Chen, A., Yang, L., Mao, Z., & Li, D. (2026). Deficiency of NR2C2 accelerates senescence of testicular Leydig cells and infertility in male mice. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2025.112284
Vancouver
Gong D, Liu Z, Kang R, Liu X, Min Z, Xin H, et al. Deficiency of NR2C2 accelerates senescence of testicular Leydig cells and infertility in male mice. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2025.112284
BibTeX
@article{Gong2026,
author = {Gong, Dalian and Liu, Zhihui and Kang, Rongda and Liu, Xiaowen and Min, Ziqian and Xin, Huan and Liu, Yanan and Chen, Yuanyuan and Liu, Min and Liang, Ying and Chen, Anji and Yang, Lifang and Mao, Zenghui and Li, Dan},
title = {Deficiency of NR2C2 accelerates senescence of testicular Leydig cells and infertility in male mice},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2025.112284}
}
EUVIMED